Activating PI3Kδ mutations in a cohort of 669 patients with primary immunodeficiency
- PMID: 26437962
- PMCID: PMC4711166
- DOI: 10.1111/cei.12706
Activating PI3Kδ mutations in a cohort of 669 patients with primary immunodeficiency
Abstract
The gene PIK3CD codes for the catalytic subunit of phosphoinositide 3-kinase δ (PI3Kδ), and is expressed solely in leucocytes. Activating mutations of PIK3CD have been described to cause an autosomal dominant immunodeficiency that shares clinical features with common variable immunodeficiency (CVID). We screened a cohort of 669 molecularly undefined primary immunodeficiency patients for five reported mutations (four gain-of-function mutations in PIK3CD and a loss of function mutation in PIK3R1) using pyrosequencing. PIK3CD mutations were identified in three siblings diagnosed with CVID and two sporadic cases with a combined immunodeficiency (CID). The PIK3R1 mutation was not identified in the cohort. Our patients with activated PI3Kδ syndrome (APDS) showed a range of clinical and immunological findings, even within a single family, but shared a reduction in naive T cells. PIK3CD gain of function mutations are more likely to occur in patients with defective B and T cell responses and should be screened for in CVID and CID, but are less likely in patients with a pure B cell/hypogammaglobulinaemia phenotype.
Keywords: B cells; PI3Kδ; common variable immunodeficiency; hypogammaglobulinaemia; primary immunodeficiency.
© 2015 British Society for Immunology.
Figures




References
-
- Grimbacher B, Hutloff A, Schlesier M et al Homozygous loss of ICOS is associated with adult‐onset common variable immunodeficiency. Nat Immunol 2003; 4:261–8. - PubMed
-
- Kok K, Geering B, Vanhaesebroeck B. Regulation of phosphoinositide 3‐kinase expression in health and disease. Trends Biochem Sci 2009; 34:115–27. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous